Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Croney CM, Nahm MH, Juhn SK, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2013 Nov;20(11):1711-8. doi: 10.1128/CVI.00381-13. Epub 2013 Sep 4.

PMID:
24006139
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A.

Daniels CC, Kim KH, Burton RL, Mirza S, Walker M, King J, Hale Y, Coan P, Rhee DK, Nahm MH, Briles DE.

Clin Vaccine Immunol. 2013 Oct;20(10):1549-58. doi: 10.1128/CVI.00371-13. Epub 2013 Aug 7.

PMID:
23925886
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response.

Perciani CT, Barazzone GC, Goulart C, Carvalho E, Cabrera-Crespo J, Gonçalves VM, Leite LC, Tanizaki MM.

Clin Vaccine Immunol. 2013 Jun;20(6):858-66. doi: 10.1128/CVI.00754-12. Epub 2013 Apr 3.

PMID:
23554468
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.

Goulart C, da Silva TR, Rodriguez D, Politano WR, Leite LC, Darrieux M.

PLoS One. 2013;8(3):e59605. doi: 10.1371/journal.pone.0059605. Epub 2013 Mar 22.

PMID:
23533636
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan.

Hotomi M, Togawa A, Kono M, Ikeda Y, Takei S, Hollingshead SK, Briles DE, Suzuki K, Yamanaka N.

PLoS One. 2013;8(3):e58124. doi: 10.1371/journal.pone.0058124. Epub 2013 Mar 6.

PMID:
23483982
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.

Infect Immun. 2013 May;81(5):1625-34. doi: 10.1128/IAI.00240-13. Epub 2013 Mar 4.

PMID:
23460513
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae.

Li Y, Gierahn T, Thompson CM, Trzciński K, Ford CB, Croucher N, Gouveia P, Flechtner JB, Malley R, Lipsitch M.

PLoS Pathog. 2012;8(11):e1002989. doi: 10.1371/journal.ppat.1002989. Epub 2012 Nov 8.

PMID:
23144610
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.

Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE.

J Immunol. 2012 Dec 1;189(11):5327-35. doi: 10.4049/jimmunol.1201967. Epub 2012 Oct 26.

PMID:
23105137
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.

Ren B, Li J, Genschmer K, Hollingshead SK, Briles DE.

Clin Vaccine Immunol. 2012 Oct;19(10):1574-82. Epub 2012 Aug 1.

PMID:
22855389
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.

Lima FA, Ferreira DM, Moreno AT, Ferreira PC, Palma GM, Ferreira JM Jr, Raw I, Miyaji EN, Ho PL, Oliveira ML.

Clin Vaccine Immunol. 2012 Sep;19(9):1382-92. doi: 10.1128/CVI.00171-12. Epub 2012 Jul 3.

PMID:
22761301
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.

Croney CM, Coats MT, Nahm MH, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2012 Jun;19(6):891-6. doi: 10.1128/CVI.05671-11. Epub 2012 Apr 25.

PMID:
22539473
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.

Wright AK, Ferreira DM, Gritzfeld JF, Wright AD, Armitage K, Jambo KC, Bate E, El Batrawy S, Collins A, Gordon SB.

PLoS Pathog. 2012;8(4):e1002622. doi: 10.1371/journal.ppat.1002622. Epub 2012 Apr 5.

PMID:
22496648
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Malley R, Anderson PW.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3623-7. doi: 10.1073/pnas.1121383109. Epub 2012 Feb 2. Review.

PMID:
22308483
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.

Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.

PMID:
22158740
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.

Kono M, Hotomi M, Hollingshead SK, Briles DE, Yamanaka N.

PLoS One. 2011;6(10):e27102. doi: 10.1371/journal.pone.0027102. Epub 2011 Oct 31.

PMID:
22073127
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.

Vintiñi EO, Medina MS.

BMC Immunol. 2011 Aug 11;12:46. doi: 10.1186/1471-2172-12-46.

PMID:
21834957
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.

Kataoka K, Fujihashi K, Oma K, Fukuyama Y, Hollingshead SK, Sekine S, Kawabata S, Ito HO, Briles DE, Oishi K.

Infect Immun. 2011 Jul;79(7):2819-28. doi: 10.1128/IAI.01360-10. Epub 2011 May 2.

PMID:
21536790
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Next generation pneumococcal vaccines.

Moffitt KL, Malley R.

Curr Opin Immunol. 2011 Jun;23(3):407-13. doi: 10.1016/j.coi.2011.04.002. Epub 2011 Apr 21. Review.

PMID:
21514128
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Apoptosis-like death in bacteria induced by HAMLET, a human milk lipid-protein complex.

Hakansson AP, Roche-Hakansson H, Mossberg AK, Svanborg C.

PLoS One. 2011 Mar 10;6(3):e17717. doi: 10.1371/journal.pone.0017717.

PMID:
21423701
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.

Mirza S, Wilson L, Benjamin WH Jr, Novak J, Barnes S, Hollingshead SK, Briles DE.

Infect Immun. 2011 Jun;79(6):2440-50. doi: 10.1128/IAI.00489-10. Epub 2011 Mar 21.

PMID:
21422179
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk